Advisor Group Holdings, Inc. Cytosorbents Corp Transaction History
Advisor Group Holdings, Inc.
- $40.6 Billion
- Q2 2024
A detailed history of Advisor Group Holdings, Inc. transactions in Cytosorbents Corp stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 112,420 shares of CTSO stock, worth $151,767. This represents 0.0% of its overall portfolio holdings.
Number of Shares
112,420
Previous 113,810
1.22%
Holding current value
$151,767
Previous $108,000
27.78%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding CTSO
# of Institutions
55Shares Held
16.9MCall Options Held
10.1KPut Options Held
500-
Avenir Corp Washington, DC2.97MShares$4.01 Million0.21% of portfolio
-
Skylands Capital, LLC2.84MShares$3.84 Million0.3% of portfolio
-
Granahan Investment Management, LLC Waltham, MA2.66MShares$3.6 Million0.08% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.95MShares$2.63 Million0.0% of portfolio
-
Neuberger Berman Group LLC New York, NY1.54MShares$2.07 Million0.0% of portfolio
About Cytosorbents Corp
- Ticker CTSO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 43,577,400
- Market Cap $58.8M
- Description
- Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...